sulfasalazine has been researched along with Deaf Mutism in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dowd, A | 1 |
| Rees, WD | 1 |
| Gibson, WS | 1 |
3 other studies available for sulfasalazine and Deaf Mutism
| Article | Year |
|---|---|
Long-standing adverse reactions.
Topics: Anorexia; Deafness; Humans; Male; Middle Aged; Sulfasalazine; Theophylline; Time Factors; Tinnitus | 1993 |
Treatment of sensorineural deafness associated with ulcerative colitis.
Topics: Adult; Azathioprine; Colitis, Ulcerative; Deafness; Humans; Male; Prednisolone; Sulfasalazine | 1987 |
Deafness due to orally administered neomycin.
Topics: Audiometry; Child; Colitis, Ulcerative; Deafness; Humans; Male; Neomycin; Prednisone; Sulfasalazine | 1967 |